Cargando…
Endpoints used in phase III randomized controlled trials of treatment options for COVID-19
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265861/ https://www.ncbi.nlm.nih.gov/pubmed/32632415 http://dx.doi.org/10.1016/j.eclinm.2020.100403 |
| _version_ | 1783541202947145728 |
|---|---|
| author | Desai, Aakash Gyawali, Bishal |
| author_facet | Desai, Aakash Gyawali, Bishal |
| author_sort | Desai, Aakash |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7265861 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72658612020-06-02 Endpoints used in phase III randomized controlled trials of treatment options for COVID-19 Desai, Aakash Gyawali, Bishal EClinicalMedicine Commentary Elsevier 2020-06-02 /pmc/articles/PMC7265861/ /pubmed/32632415 http://dx.doi.org/10.1016/j.eclinm.2020.100403 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Commentary Desai, Aakash Gyawali, Bishal Endpoints used in phase III randomized controlled trials of treatment options for COVID-19 |
| title | Endpoints used in phase III randomized controlled trials of treatment options for COVID-19 |
| title_full | Endpoints used in phase III randomized controlled trials of treatment options for COVID-19 |
| title_fullStr | Endpoints used in phase III randomized controlled trials of treatment options for COVID-19 |
| title_full_unstemmed | Endpoints used in phase III randomized controlled trials of treatment options for COVID-19 |
| title_short | Endpoints used in phase III randomized controlled trials of treatment options for COVID-19 |
| title_sort | endpoints used in phase iii randomized controlled trials of treatment options for covid-19 |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265861/ https://www.ncbi.nlm.nih.gov/pubmed/32632415 http://dx.doi.org/10.1016/j.eclinm.2020.100403 |
| work_keys_str_mv | AT desaiaakash endpointsusedinphaseiiirandomizedcontrolledtrialsoftreatmentoptionsforcovid19 AT gyawalibishal endpointsusedinphaseiiirandomizedcontrolledtrialsoftreatmentoptionsforcovid19 |